A major US AIDS group filed a competition complaint against GlaxoSmithKline Plc in South Africa on Tuesday, saying its high prices block HIV-infected patients from receiving antiretroviral drugs.
“GSK’s stranglehold on key AIDS drug patents and their unfettered monopoly pricing on these life-saving medications means thousands of deaths daily,” AIDS Healthcare Foundation President Michael Weinstein said in a statement.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!